CHLOROPROCAINE HCI
NESACAINE(R) (CHLOROPROCAINE HCI INJECTION, USP) 2% (600mg per 30mL) (20mg per mL) 30mL VIAL
Approved
Approval ID
94d13f48-fbc6-67b4-e053-2995a90a791b
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Jan 22, 2024
Manufacturers
FDA
HF Acquisition Co LLC, DBA HealthFirst
DUNS: 045657305
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
CHLOROPROCAINE HCI
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code51662-1401
Application NumberNDA009435
Product Classification
M
Marketing Category
C73594
G
Generic Name
CHLOROPROCAINE HCI
Product Specifications
Route of AdministrationINFILTRATION, PERINEURAL
Effective DateJanuary 22, 2024
FDA Product Classification
INGREDIENTS (6)
SODIUM CHLORIDEInactive
Quantity: 4.7 mg in 1 mL
Code: 451W47IQ8X
Classification: IACT
EDETATE DISODIUMInactive
Quantity: 0.111 mg in 1 mL
Code: 7FLD91C86K
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT
CHLOROPROCAINE HYDROCHLORIDEActive
Quantity: 20 mg in 1 mL
Code: LT7Z1YW11H
Classification: ACTIB
METHYLPARABENInactive
Quantity: 1 mg in 1 mL
Code: A2I8C7HI9T
Classification: IACT